Codiak BioSciences, Inc.·4

Feb 18, 4:05 PM ET

Brudnick Richard 4

4 · Codiak BioSciences, Inc. · Filed Feb 18, 2022

Insider Transaction Report

Form 4
Period: 2022-02-16
Brudnick Richard
See Remarks
Transactions
  • Award

    Stock Option (Right to Buy)

    2022-02-16+10,85010,850 total
    Exercise: $5.21Exp: 2032-02-15Common Stock (10,850 underlying)
  • Award

    Restricted Stock Units

    2022-02-16+16,27516,275 total
    Common Stock (16,275 underlying)
Footnotes (3)
  • [F1]25% of this option shall vest and become exercisable on February 16, 2023, with the remainder vesting in 12 equal quarterly installments thereafter.
  • [F2]Each restricted stock unit represents a contingent right to receive one share of common stock.
  • [F3]On February 16, 2022, the reporting person was granted 16,275 restricted stock units, vesting in four equal installments every six months beginning on the six month anniversary of the grant date.

Documents

1 file
  • 4
    doc4.xmlPrimary

    FORM 4 SUBMISSION